We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,359

Clinical trials in France
  • Reed Smith LLP
  • France, Global
  • February 19 2018

A structured guide to clinical trials in France


Da Volterra Develops Device to Combat Antibiotic Resistance
  • Knobbe Martens
  • USA
  • February 11 2018

Da Volterra, a biotech company developing products in the antibacterial field, has announced results in a human clinical trial for DAV132, a product


EU General Court rules on transparency of clinical trial data
  • Allen & Overy LLP
  • European Union
  • February 6 2018

Today, the General Court delivered three landmark judgments relating to transparency of clinical trial data in the EU. The long-awaited rulings


Clinical trials in Switzerland
  • Bär & Karrer
  • Switzerland, Global
  • January 24 2018

A structured guide to clinical trials in Switzerland


California Court of Appeal Limits Duty of Clinical Study Sponsor to Intervene in Treaters’ Care of Study Participants
  • Reed Smith LLP
  • USA
  • January 12 2018

Last week, we took a short Western Caribbean cruise to celebrate a jarringly-advanced birthday. While the weather wasn’t an asset (it was 43 degrees


CFDA seeks comments for compassionate use of drugs in clinical trials, 15 December
  • CMS
  • China
  • January 8 2018

CFDA published the draft Administrative Measures for Drugs Compassionately used in Extended Clinical Trials (Draft for Comment) ("Draft") on 15


Clinical Trial Hypothesis Doesn’t Constitute Reasonable Expectation of Success
  • McDermott Will & Emery
  • USA
  • December 29 2017

Addressing the issues of reasonable expectation of success and induced infringement of claims directed to a method of treatment in a particular


Totality of Evidence Must Be Considered in Assessing Obviousness
  • McDermott Will & Emery
  • USA
  • December 29 2017

The US Court of Appeals for the Federal Circuit reversed a finding of non-obviousness, concluding that the district court clearly erred in relying on


Rare Pediatric Disease Clinical Trials Get New Lift from EMA-Inspired Gaucher Model
  • Arent Fox LLP
  • USA
  • December 13 2017

On December 6, 2017, FDA announced a new approach for pediatric disease drug development that the Agency believes will reduce the number of patients


Healthcare’s new era: Why administrative healthcare data is key
  • Conduent
  • USA
  • December 1 2017

The changes have seemed endless. Since the early days of “Meaningful Use” electronic healthcare records incentives, to the recent switch to an